I am a healthcare professional

Notice


Welcome to MEDICALLY. This website is a non-promotional international resource intended to facilitate transparent scientific exchange regarding developments in medical research and disease management. It is intended for healthcare professionals outside the United Kingdom (UK) and Australia. The content on this website may include scientific information about experimental or investigational compounds, indications and services that are not approved or valid in your jurisdiction. Registration status and prescribing information of medicinal products may differ between countries. Roche and Genentech do not support, endorse or recommend the unapproved use of any compound or service in your jurisdiction, including those discussed on this website.


Please refer to local product information for any medicinal products mentioned. Information available on this website does not constitute professional medical advice, and Roche and Genentech accept no responsibility for access to or use of the same. Healthcare professionals outside the US are required to register and log-in to access the full range of content available on this website.


By clicking on one of the healthcare professional buttons below, you acknowledge you have read and understood this message and that you are requesting access to MEDICALLY. If you are not a healthcare professional, please use the other links below to access information relevant to you.


Cookies


We use cookies on this site to enable the site to function properly and to enhance your user experience. Cookies are files stored in your browser, which most websites use to personalize your web experience. Your information will only be used to provide information that is relevant to you. It will not be used for any other purpose. If you wish to restrict or block cookies, which are set on your device, then you can do this through your browser settings.


You can find out more about cookies by browsing our Privacy Policy.

 

For healthcare professionals in Another Country browse medically.roche.com.

Not a healthcare professional? For individuals outside the US, browse Roche's patient website or roche.com. For individuals in the US, browse gene.com.

External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Roche and Genentech at

AMCP Nexus 2021

-
Coming soon

Sign up or login to unlock the full suite of MEDICALLY features

Oct 21 / Roche and Genentech
Assessing Perceived Vision, Functional Status, and Related Health Care Cost of Patients With Neovascular Age-Related Macular Degeneration (nAMD) and Diabetic Macular Edema (DME): Analysis of the Medicare Current Beneficiary Survey (MCBS) Data
The Medicare Current Beneficiaries Survey (MCBS) is a continuous, in-person longitudinal survey that collects data on beneficiaries’ health insurance coverage, health and function status, and health care utilization and costs. This poster reports the sociodemographic and clinical characteristics, perceived vision and function status, and health care costs due to intravitreal injections of Medicare beneficiaries with neovascular age-related macular degeneration, diabetic macular edema, or retinal vein occlusion from MCBS data.

Sign up or login to unlock the full suite of MEDICALLY features

Oct 21 / Roche and Genentech
Identifying Barriers to Adherence to Anti-VEGF Therapies in Neovascular Age Related Macular Degeneration (nAMD) and Diabetic Macular Edema (DME): A Mixed Method Approach to Understand Patient Treatment Experience
This presentation explores the US findings from an international qualitative study of the current treatment experiences, satisfaction, and barriers to adherence in nAMD and DME from patients’, caregivers’, and physicians’ perspectives.

Sign up or login to unlock the full suite of MEDICALLY features

Personalised Healthcare
Oct 20 / Roche and Genentech
Adherence and persistence to nusinersen using commercial claims data
This retrospective, claims analysis aimed to describe the real-world adherence and persistence of nusinersen-treated patients with SMA among commercially insured patients in the US.
10:00 AM
Duration 8mins Virtual
Adherence and persistence to nusinersen using commercial claims data
David Fox, Tu My To, Arpamas Seetasith, Anisha Patel, Susan Iannaccone

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar